2016 Clinical Breast Imaging: A Multidisciplinary Approach – A Video CME Teaching Activity

Session 1

Breast MRI Acquisition: What is Needed
Christopher Comstock, M.D.

How to Interpret Breast MRI
Janice S. Sung, M.D.

The New MRI BI-RADS^®
Elizabeth A. Morris, M.D., FACR

Breast MRI Indications and Utilization
Carol H. Lee, M.D.

Session 2

MRI CAD: Necessary or Not?
Christopher Comstock, M.D.

What is the Hype with Background Parenchymal Enhancement?
Elizabeth A. Morris, M.D., FACR

Incidental Enhancing Lesions on MRI
Carol H. Lee, M.D.

Breast MRI Case Review
Christopher Comstock, M.D.

Session 3

Screening Controversies & Breast Density
Carol H. Lee, M.D.

The Spectrum of ADH & DCIS: When Is It Overdiagnosis?
Adriana Corben, M.D., FACP

Surgical Management of DCIS
Virgilio Sacchini, M.D.

Understanding Risk & Risk Models
Allison W. Kurian, M.D., M.Sc.

Session 4

Breast Cancer Genetics
Allison W. Kurian, M.D., M.Sc.

Supplemental Screening CEDM, MRI, MBI
Janice S. Sung, M.D.

Risk Adapted Screening for Breast Cancer
Allison W. Kurian, M.D., M.Sc.

Debate: Preoperative Breast MRI – Should We Do It?
Christopher Comstock,M.D.
Elizabeth A. Morris, M.D.

Session 5

The Many Biological Faces of Breast Cancer
Allison W. Kurian, M.D., M.Sc.

Pathology Stains: What Are We Looking At?
Adriana Corben, M.D., FACP

Imaging Margin Assessment
Carol H. Lee, M.D.

Pathologic Margin Assessment: How Is It Done?
Adriana Corben, M.D., FACP

Session 6

Radioactive Seed Localization
Janice S. Sung, M.D.

Oncoplastic Surgery, Implants & Autologous Reconstruction
Virgilio Sacchini, M.D.

Imaging After Oncoplastic Surgery & Implants
Elizabeth A. Morris, M.D., FACR

Nipple Sparing Mastectomy: Why, When, How
Virgilio Sacchini, M.D.

Session 7

Optimizing Targeted Chemotherapy in the Era of Personalized Medicine
Allison W. Kurian, M.D., M.Sc.
Elizabeth A. Morris, M.D.

Pathology Assessment After Neoadjuvant Chemotherapy
Adriana Corben, M.D., FACP

Sentinel Node Biopsy in Neoadjuvant Chemotherapy
Virgilio Sacchini, M.D.

Radiologic Management of the Axilla
Christopher Comstock, M.D. 

Session 8

Biopsy Under Ultrasound and Stereotactic Guidance: What is New?
Janice S. Sung, M.D.

MRI Guided Breast Biopsy
Carol H. Lee, M.D.

High Risk Lesions: What to Excise?
Adriana Corben, M.D., FACP

Case Based BI-RADS^® Update
Carol H. Lee, M.D.

Session 9

Tomosynthesis in Clinical Practice
Janice S. Sung, M.D.

Debate: Should We Be Doing Screening US?
Carol H. Lee, M.D.
Janice S. Sung, M.D.

Management of the Palpable Breast Mass
Carol H. Lee, M.D.

How to Monitor for Breast Cancer Recurrence
Janice S. Sung, M.D.

Session 10

Positioning in MRI: Basics Make for the Best Outcome Quality
Robyn Birdwell, M.D., FACR

Update on MRI BI-RADS^®
Stamatia V. Destounis, M.D., FACR

Normal Background Enhancement in Breast MRI
Robyn L. Birdwell, M.D., FACR

MRI of the High Risk Patient
Stamatia V. Destounis, M.D., FACR

Session 11

MRI in the Post Treated Breast: Benign and Malignant Procedures
Robyn L. Birdwell, M.D., FACR

Screening Breast Ultrasound: Techniques and Controversies
Regina J. Hooley, M.D.

BI-RADS^® for US: Update
Marcela Bohm-Velez, M.D., FACR

Session 12

Ultrasound Evaluation of the Breast: How to Improve Sensitivity and Specificity
Regina J. Hooley, M.D.

Breast Microcalcifications and Axillary Lymph Nodes: How Can Ultrasound Help?
Regina J. Hooley, M.D.